IQVIA Stock Pops As Analysts Hike Price Targets Again

IQVIA Holdings Inc. (IQV) stock surged by 12.12% recently, driven by news of a transformative clinical data-analytics partnership and multiple analyst price target hikes. Firms like HSBC and Deutsche Bank have raised their targets, citing anticipated healthcare outperformance and overstated fears regarding AI/ML disruption. The company's upcoming Q2 2026 earnings release and its R&D leader's testimony before a U.S. House subcommittee are also seen as significant catalysts.